Microdosing: A Critical Assessment of Human Data-Reference-Cited by-同舟云学术

Microdosing: A Critical Assessment of Human Data

Published:2012-11 Issue:11 Volume:101 Page:4067-4074
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Rowland Malcolm

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Big physics, small doses: The use of AMS and PET in human microdosing of development drugs;Lappin;Nat Rev Drug Discov,2003

2. The utility of microdosing over the past 5years;Lappin;Expert Opin Drug Metab Toxicol,2008

3. Impact of microdosing clinical study—Why necessary and how useful?;Sugiyama;Adv Drug Deliv Rev,2011

4. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?;Beaumont;Curr Opin Drug Discov Dev,2009

5. PHRMA CPCDC Initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the wajima approach;Vuppugalla;J Pharm Sci,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients;Cancer Chemotherapy and Pharmacology;2024-06-29

2. Molecular Design and Synthetic Strategy toward Development of PET Probes;Journal of Synthetic Organic Chemistry, Japan;2024-05-01

3. Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance;Drug Metabolism and Disposition;2023-03-27

4. A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens;Clinical and Translational Science;2022-11-23

5. Phase 0/microdosing approaches: time for mainstream application in drug development?;Nature Reviews Drug Discovery;2020-09-08